Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Insertion of Mini-IS605 and Deletion of Adjacent Sequences in the Nitroreductase (rdxA) Gene Cause Metronidazole Resistance in Helicobacter pyloriNCTC11637

Yvette J. Debets-Ossenkopp, Raymond G. J. Pot, David J. van Westerloo, Avery Goodwin, Christina M. J. E. Vandenbroucke-Grauls, Douglas E. Berg, Paul S. Hoffman, Johannes G. Kusters
Yvette J. Debets-Ossenkopp
Department of Medical Microbiology and Infection Control, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond G. J. Pot
Department of Medical Microbiology and Infection Control, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. van Westerloo
Department of Medical Microbiology and Infection Control, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avery Goodwin
Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina M. J. E. Vandenbroucke-Grauls
Department of Medical Microbiology and Infection Control, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas E. Berg
Department of Molecular Microbiology, Washington University, St. Louis, Missouri; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul S. Hoffman
Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes G. Kusters
Department of Medical Microbiology and Infection Control, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.43.11.2657
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We found that NCTC11637, the type strain of Helicobacter pylori, the causative agent of peptic ulcer disease and an early risk factor for gastric cancer, is metronidazole resistant. DNA transformation, PCR-based restriction analysis, and DNA sequencing collectively showed that the metronidazole resistance of this strain was due to mutation in rdxA (gene HP0954 in the full genome sequence of H. pylori 26695) and that resistance did not depend on mutation in any of the other genes that had previously been suggested: catalase (katA), ferredoxin (fdx), flavodoxin (fldA), pyruvate:flavodoxin oxidoreductase (porγδαβ), RecA (recA), or superoxide dismutase (sodB). This is in accord with another recent study that attributed metronidazole resistance to point mutations inrdxA. However, the mechanism of rdxAinactivation that we found in NCTC11637 is itself also novel: insertion of mini-IS605, one of the endogenous transposable elements of H. pylori, and deletion of adjacent DNA sequences including 462 bp of the 851-bp-long rdxA gene.

Helicobacter pylori is a microaerophilic gram-negative bacterium that chronically infects the gastric mucosa of more than half of all persons worldwide and is a major cause of chronic active gastritis and peptic ulcer disease (23) and an early risk factor for gastric cancer (17). Antimicrobial therapy that leads to eradication of infection and ulcer healing is often achieved with metronidazole, a nitroheterocyclic compound [1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole], in combination with other drugs (30). Resistance to metronidazole is common, however, and is the major factor in many cases of failure to eradicateH. pylori and cure the disease (6, 20, 24).

For metronidazole to kill H. pylori, it must be taken up by an energized membrane (22) and then reduced to form a toxic metabolite. Several mechanisms of metronidazole resistance have been proposed in recent years, including enhanced scavenging of toxic oxygen radicals by an altered catalase or superoxide dismutase (7, 11, 26), a more efficient DNA damage repair mechanism (9, 27), and loss of function of a critical reductase (15, 16). Recent studies of fresh clinical isolates by several of us (12) indicated that metronidazole resistance often results from point mutation in rdxA (HP0954, in the fully sequenced genome of strain 26695 [28]), a gene that encodes an oxygen-insensitive NADPH nitroreductase. However, some researchers have questioned the generality of this interpretation (13, 21).

Here we report that NCTC11637, the type strain of H. pylorithat Barry Marshall had isolated in Australia and that we obtained from the American Type Culture Collection, displays a high level of resistance to metronidazole and that this resistance is attributable to mutational inactivation of rdxA. Our experiments further suggest that mutation in other genes, previously invoked to explain the metronidazole resistance phenomenon, does not contribute to the high-level metronidazole resistance of NCTC11637 (katA[catalase], fdx [ferredoxin], fldA[flavodoxin], porγδαβ [pyruvate:flavodoxin oxidoreductase], recA [RecA], and sodB[superoxide dismutase]).

MATERIALS AND METHODS

Bacterial strains and growth conditions. H. pyloristrains used in this study were NCTC11637 (MIC of >256 μg/ml) (obtained from the American Type Culture Collection as ATCC 43504), which was found here to be metronidazole resistant (Mtzr) (3), and the unrelated, metronidazole-susceptible (Mtzs) strain NCTC11638 (MIC of <0.032 μg/ml). Bacteria were routinely grown on Dent plates (Columbia agar plates supplemented with 7% lysed horse blood and H. pylori selective supplement [Oxoid, Basingstoke, United Kingdom]). Plates were incubated at 37°C in a microaerophilic atmosphere of 5% O2–10% CO2–85% N2.

Determination of MIC.MICs were determined with the Etest as described before (10).

Natural transformation.Metronidazole-resistant NCTC11638 transformants were created by natural transformation of NCTC11638 (Mtzs) with DNA from the NCTC11637 (Mtzr) strain, essentially as described by Wang et al. (31). As a control, bacteria were transformed with TE (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) instead of DNA. Transformants (selected on Dent plates containing 32 μg of metronidazole per ml) were generated at a frequency of 10−5 per viable cell. From one such experiment, 12 individual colonies were selected at random, and the metronidazole MICs were determined.

PCR.Unless noted otherwise, standard techniques were used for all DNA manipulations (5). Primers (Table1) for PCR amplification were based on the full genome sequence of strain 26695 (28) plus other entries in the public database. PCR was performed in an automated thermal cycler (Mastercycler 5330; Eppendorf, Hamburg, Germany), in a final volume of 100 μl by using the Primezym DNA polymerase kit (Biometra, Göttingen, Germany), with approximately 2.5 ng of template genomic DNA and 100 pmol of each primer. Amplification conditions are listed in Table 1. The size of the PCR products was evaluated by electrophoresis on a 1.5% agarose–0.5× Tris-borate-EDTA gel containing 0.5 μg of ethidium bromide per ml.

View this table:
  • View inline
  • View popup
Table 1.

Oligonucleotide primers used in this study

Cloning and sequencing of the PCR products.PCR products were ligated into the pGEM-T vector (Promega, Madison, Wis.) according to the manufacturer’s recommendations. The ligation products were then transformed into Escherichia coli ER1793 (18), and transformants were selected on Luria-Bertani plates supplemented with 100 μg of ampicillin per ml. Plasmid DNA was isolated from transformants with the QIAprep spin plasmid (Qiagen, Hilden, Germany). These plasmids were then used as templates for DNA sequencing with the Thermo-Sequenase premixed cycle sequencing kit (Amersham, Little Chalfont, Buckinghamshire, United Kingdom) with the M13 forward and reverse primers. Sequencing was performed on an Amersham Vistra 725 DNA sequencer, and data were analyzed with Lasergene software (DNASTAR, Madison, Wis.).

Restriction fragment length polymorphism (RFLP).Approximately 300 ng of PCR product was digested with restriction endonucleases (New England Biolabs, Beverly, Mass.). The endonucleases used for RFLP analysis of the various genes are indicated in Table 1. The restriction enzyme digestion profile was subsequently analyzed by electrophoresis on a 1.5% agarose gel.

RESULTS

Metronidazole-resistant transformant derivatives of NCTC11638.The type strain, NCTC11637, is resistant to metronidazole (MIC of >256 μg/ml). We used a DNA transformation and PCR product characterization strategy to determine the basis of its resistance. This was based on findings that Mtzr determinants can be transferred to Mtzs strains by transformation (31) and that the differences in distributions of restriction sites in a given gene from unrelated strains usually allow those strains to be distinguished (1). Mtzr (32 μg/ml) transformant derivatives of NCTC11638 were obtained at a frequency of approximately 10−5 per recipient cell with NCTC11637 genomic DNA, in contrast to a frequency of <10−7 per recipient cell in DNA-free mock-transformation controls. Each of the 12 transformants tested, although selected at 32 μg/ml, was resistant to more than 256 μg/ml, as was its Mtzr NCTC11637 parent.

RFLP analysis of the selected genes.A number of different genes (fdx [ferredoxin], fldA [flavodoxin],porγδαβ [pyruvate:flavodoxin oxidoreductase],recA [RecA], katA [catalase], andsodB [superoxide dismutase]) had been postulated by various other groups to contribute to high-level Mtzr. The possible involvement of any of them was tested by scoring whether the Mtzr transformants contained NCTC11637-type or NCTC11638-type alleles at these loci in an RFLP test. First, primers for amplification of these genes were designed (Table 1), based on the sequences in the public databases. PCR products of the expected size were obtained from the NCTC11637 donor DNA, from the NCTC11638 recipient, and from each transformant.

To maximize the power of RFLP analysis and to get a better sense of the sequence divergence of these two much-studied strains, we PCR amplified and sequenced each of the candidate genes and thereby identified restriction sites that differed usefully between the parental strains. The PCR product corresponding to each candidate gene from each of the 12 Mtzr transformants was then analyzed by restriction with appropriate enzymes (Table 1).

In each case, except for rdxA (see below), the results showed unambiguously that the Mtzr transformants contained alleles of the Mtzs NCTC11638 recipient at each of these loci. This is exemplified by the Sau3AI and MseI RFLP patterns of sodB shown in Fig.1. Thus, the ability of NCTC11637 genomic DNA to transform NCTC11638 to Mtzr did not depend on acquisition of special donor alleles of any of these previously suggested candidate genes.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Ethidium bromide-stained agarose gel displaying the restriction endonuclease digestion pattern of the sodBamplicon. (A) Digestion with Sau3AI; (B) digestion withMseI. Lane 1, H. pylori NCTC11638 (Mtzs); lane 2, H. pylori NCTC11637 (Mtzr); lanes 3 to 14, H. pylori NCTC11638 transformants (Mtzr). The positions of the molecular size markers (1-kb ladder; Stratagene) are indicated on the left.

In contrast to these negative results, PCR amplification from NCTC11637rdxA, the gene whose inactivation had been implicated recently in the Mtzr of fresh clinical isolates, yielded a product of 650 bp, 200 bp smaller than expected from the published sequences and as observed with NCTC11638 (Fig.2). Each of the 12 Mtzrtransformants of NCTC11638 also yielded a product of only 650 bp with the rdxA-specific primers. This result indicated that the Mtzr of NCTC11637 was due to mutation in rdxA. Independent confirmation for the involvement of rdxA in the Mtzr phenotype of strain NCTC11637 was obtained by transformation of wild-type NCTC11638 with the aberrant 650-bp PCR product obtained from NCTC11637. This resulted in high numbers of Mtzr transformants, while no such transformants were observed in the control transformation, where we used the 850-bprdxA PCR fragment obtained from strain NCTC11638.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Ethidium bromide-stained agarose gel of therdxA amplicon. Lane 1, H. pylori NCTC11638 (Mtzs); lane 2, H. pylori NCTC11637 (Mtzr); lanes 3 to 14, H. pylori NCTC11638 transformants (Mtzr). The positions of the molecular size markers (1-kb ladder; Stratagene) are indicated on the left.

Sequence analysis of the rdxA genes.The basis of the unexpected shortness of the NCTC11637 rdxA locus was determined by sequencing. In the donor strain and also in the transformants analyzed, we found an insertion of a novel 260-bp segment just before the start of HP0953 (the gene just downstream ofrdxA) and a deletion of a 462-bp segment including 177 bp from the 3′ end of rdxA (Fig.3). A BLAST search showed that 41 and 33 bp at the left and right ends, respectively, of this 260-bp element are closely matched to the corresponding left and right ends of the 2-kb insertion sequence (IS) IS650, whereas its central 186 bp were unrelated to sequences in full-length IS605(2). Rather, this segment corresponded to the mini-IS605 (Fig. 4) that was found at the right end of the cag pathogenicity island in one strain (NCTC11638, where it is referred to as is605, in contrast to IS605) (8). The genome sequence of the fully sequenced strain 26695 contains eight such mini-IS650 elements (Fig. 4), but none is in itscag pathogenicity island (28). Just after we submitted the manuscript, the complete genomic DNA sequence of H. pylori J99 was published (4), and this sequence reveals the presence of five partial IS605 elements (Fig. 4).

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Alignment of the DNA sequences and the predicted encoded proteins of the rdxA amplicons. Mtzs, H. pylori NCTC11638; Mtzr, H. pylori NCTC11637 and the metronidazole-resistant transformants of NCTC11638. The sequence of the donor NCTC11637 amplicon is identical to that of all the metronidazole-resistant NCTC11638 transformants. The primers used to amplify the rdxA region (and amino acids derived therefrom) are indicated in boldface; the inverted repeats of the IS605 (7) are in boldface and underlined. The amino acids directly above the DNA sequence correspond to H. pylori NCTC11638; the ones directly below the DNA sequence correspond to NCTC11637 and the transformants. Gaps in the DNA sequence are marked with dashes, and identical nucleotides are indicated by dots.

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Alignment of the mini-IS605 sequence present in the rdxA gene from strain NCTC11637 (see Fig. 3); thecag pathogenicity island (cag PAI) of strain NCTC11638 (7), GenBank accession no. U60176 bp 22476 to 22735; one of the eight partial copies of IS605 present in strain 26695 (27), GenBank accession no. HPAE000537 bp 2867 to 2606; and one of the five partial copies present in strain J99 (4), GenBank accession no. HPAE000537 bp 2633 to 2891. The inverted repeats of IS605 (7) are indicated in boldface and underlined. For definitions of the dots and dashes, please see the legend to Fig. 3.

DISCUSSION

The results of our study of the type strain NCTC11637 confirm the conclusions of Goodwin et al. (12) that inactivation ofrdxA is responsible for much or all of the high-level metronidazole resistance so often seen with H. pyloriclinical isolates. There was no evidence that mutation insodB, katA, ferredoxin, flavodoxin,porγδαβ, or recA genes made any contribution to the high-level metronidazole resistance of NCTC11637. Although the PCR products for the above loci did not always cover the complete gene, it is generally assumed (as was confirmed by our analysis of the rdxA gene sequences) that natural transformation results in the exchange of a large fragment of DNA. Hence, not finding any indications for gene exchange in the central portion of these six genes in 12 independent Mtz-resistant transformants provides strong evidence against the involvement of these genes and the loci adjacent to them. However, our data do not exclude the possibility that, for the low-level resistance that is observed with some H. pylori strains (13), these genes may still play a role. Only determination of enzyme activities can provide the definitive proof for the relative contribution of each gene in the Mtzr of an individual strain.

All Mtzr mutations in rdxA that Goodwin et al. had observed were small point mutations (base substitutions), whereas the loss of RdxA function in NCTC11637 was caused by a deletion of much of the rdxA gene, associated with insertion of mini-IS605. This is a novel transposable element that does not contain any significant open reading frame and that accordingly, we conjecture, may depend on another, larger element such as full-length (2 kb) IS605 for its movement. Associated with mini-IS605 in this strain was a deletion that removed 462 bp of rdxA. Several different IS elements that are not related to IS605 or mini-IS605 had been shown in other species to generate deletions adjacent to their sites of insertion (14, 25, 29). In two cases at least (IS1 and IS50) (25, 32), deletion is independent ofrecA function, and we propose that an equivalent IS element-mediated adjacent-deletion process may have operated here. In one scenario, mini-IS605 was inserted betweenrdxA and the adjacent HP0953 gene, leaving a strain that was still metronidazole susceptible but highly prone to mutate to Mtzr by adjacent deletion. An alternative possibility of insertion and concomitant deletion has not been ruled out.

This is the first report of a transposon-based spontaneous mutation associated with antibiotic resistance in H. pylori. However, some one-third of strains from Europe and the Americas carry full-length IS605, a similar fraction carry the distantly related IS606 element, and more than half of the strains seem to carry mini-IS605 (whether full-length IS605 is present or not) (19). Endogenous IS elements are well known in other species as agents of spontaneous mutation and genome rearrangements and evolution. We propose that they may function similarly in H. pylori, perhaps often contributing to drug resistance in the face of mounting antibiotic usage and other adaptive changes of considerable evolutionary significance.

ACKNOWLEDGMENTS

This work was supported by the Netherlands Digestive Disease Foundation, the Medical Research Council of Canada grant R-14292 and Astra Canada, and the National Institutes of Health (DK48029, AI38166, and HG00820).

We thank A. B. Brinkman for his technical support.

FOOTNOTES

    • Received 19 January 1999.
    • Returned for modification 19 April 1999.
    • Accepted 27 August 1999.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Akopyants N.,
    2. Bukanov N. O.,
    3. Westblom T. U.,
    4. Berg D. E.
    PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori. Nucleic Acids Res. 20 1992 6221 6225
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Akopyants N. S.,
    2. Clifton S. W.,
    3. Kersulyte D.,
    4. Crabtree J. E.,
    5. Youree B. E.,
    6. Reece C. A.,
    7. Bukanov N. O.,
    8. Drazek E. S.,
    9. Roe B. A.,
    10. Berg D. E.
    Analysis of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28 1998 37 53
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Akopyants N. S.,
    2. Jiang Q.,
    3. Taylor D. E.,
    4. Berg D. E.
    Corrected identity of isolates of Helicobacter pylori reference strain NCTC11637. Helicobacter 2 1997 48 52
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Alm R. A.,
    2. Ling L. S.,
    3. Moir D. T.,
    4. King B. L.,
    5. Brown E. D.,
    6. Doig P. C.,
    7. Smith D. R.,
    8. Noonan B.,
    9. Guild B. C.,
    10. deJonge B. L.,
    11. Carmel G.,
    12. Tummino P. J.,
    13. Caruso A.,
    14. Uria-Nickelsen M.,
    15. Mills D. M.,
    16. Ives C.,
    17. Gibson R.,
    18. Merberg D.,
    19. Mills S. D.,
    20. Jiang Q.,
    21. Taylor D. E.,
    22. Vovis G. F.,
    23. Trust T. J.
    Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397 1999 176 180
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Ausubel F. M.,
    2. Brent R.,
    3. Kingston R. E.,
    4. Moore D. D.,
    5. Seidman J. G.,
    6. Smith J. A.,
    7. Struhl K. S.
    Current protocols in molecular biology. 1989 Greene Publishing and Wiley Interscience New York, N.Y
  6. 6.↵
    1. Buckley M. J.,
    2. Xia H. X.,
    3. Hyde D. M.,
    4. Keane C. T.,
    5. Morain C. A.
    Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig. Dis. Sci. 42 1997 2111 2115
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Cederbrant G.,
    2. Kahlmeter G.,
    3. Ljungh A.
    Proposed mechanism for metronidazole resistance in Helicobacter pylori. J. Antimicrob. Chemother. 29 1992 115 120
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Censini S.,
    2. Lange C.,
    3. Xiang Z.,
    4. Crabtree J. E.,
    5. Chiara P.,
    6. Borodovsky M.,
    7. Rappuoli R.,
    8. Covacci A.
    Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease associated virulence factors. Proc. Natl. Acad. Sci. USA 93 1996 14648 14653
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Chang K. C.,
    2. Ho S. W.,
    3. Yang J. C.,
    4. Wang J. T.
    Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori. Biochem. Biophys. Res. Commun. 236 1997 785 788
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Debets-Ossenkopp Y. J.,
    2. Brinkman A. B.,
    3. Kuipers E. J.,
    4. Vandenbroucke-Grauls C. M. J. E.,
    5. Kusters J. G.
    Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 42 1998 2749 2751
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Edwards D. I.
    Nitroimidazole drugs: action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31 1993 9 20
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Goodwin A.,
    2. Kersulyte D.,
    3. Sisson G.,
    4. Veldhuysen van Zanten S. J. O.,
    5. Berg D. E.,
    6. Hoffman P. S.
    Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol. Microbiol. 28 1998 383 393
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Graham D. Y.
    Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 115 1998 1272 1277
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Habermann P.,
    2. Starlinger P.
    Bidirectional deletions associated with IS4. Mol. Gen. Genet. 185 1982 216 222
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Hoffman P. S.,
    2. Goodwin A.,
    3. Johnsen J.,
    4. Magee K.,
    5. Veldhuyzen van Zanten S. J. O.
    Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J. Bacteriol. 178 1996 4822 4829
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Hughes N. J.,
    2. Chalk P. A.,
    3. Clayton C. L.,
    4. Kelly D. J.
    Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori. J. Bacteriol. 177 1995 3953 3959
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    IARC (EUROGAST Study Group) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 1993 1359 1362
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Kelleher J. E.,
    2. Raleigh E. A.
    A novel activity in Escherichia coli K-12 that directs restriction of DNA modified at CG dinucleotide. J. Bacteriol. 173 1991 5220 5223
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Kersulyte D.,
    2. Akopyants N. S.,
    3. Clifton S. W.,
    4. Roe B. A.,
    5. Berg D. E.
    Novel sequence organization and insertion specificity of IS605 and IS606: chimaeric transposable elements of Helicobacter pylori. Gene 223 1998 175 186
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Logan R. P. H.,
    2. Gummet P. A.,
    3. Misiewicz J. J.,
    4. Karim Q. N.,
    5. Walker M. M.,
    6. Baron J. H.
    One week eradication regimen for Helicobacter pylori. Lancet 338 1991 1249 1252
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Mégraud F.
    Epidemiology and mechanism of antibiotic resistance in H. pylori. Gastroenterology 115 1998 1278 1282
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Moore R. A.,
    2. Beckthold B.,
    3. Bryan L. E.
    Metronidazole uptake in Helicobacter pylori. Can. J. Microbiol. 41 1995 746 749
    OpenUrlPubMed
  23. 23.↵
    NIH Consensus Conference H. pylori in peptic ulcer disease. JAMA 272 1994 65 69
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Noach L. A.,
    2. Langenberg W. L.,
    3. Bertola M. A.,
    4. Dankert J.,
    5. Tytgat G. N. J.
    Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand. J. Infect. Dis. 26 1994 321 327
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Reif H. J.,
    2. Saedler H.
    IS1 is involved in deletion formation in the gal region of E. coli K12. Mol. Gen. Genet. 137 1975 17 28
    OpenUrlPubMedWeb of Science
  26. 26.↵
    1. Smith M. A.,
    2. Edwards D. I.
    Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J. Antimicrob. Chemother. 35 1995 751 764
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Thompson S. A.,
    2. Blaser M. T.
    Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH. Infect. Immun. 63 1995 2185 2193
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Tomb J. F.,
    2. White O.,
    3. Kerlavage A. R.,
    4. Clayton R. A.,
    5. Sutton G. G.,
    6. Fleischmann R. D.,
    7. Ketchum K. A.,
    8. Klenk H. P.,
    9. Gill S.,
    10. Dougherty B. A.,
    11. Nelson K.,
    12. Quackenbush J.,
    13. Zhou L.,
    14. Kirkness E. F.,
    15. Peterson S.,
    16. Loftus B.,
    17. Richardson D.,
    18. Dodson R.,
    19. Khalak H. G.,
    20. Glodek A.,
    21. McKenney K.,
    22. Fitzegerald L. M.,
    23. Lee N.,
    24. Adams M. D.,
    25. Venter J. C.
    The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 1997 539 547
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Tomcsanyi T.,
    2. Berg C. M.,
    3. Phadnis S. H.,
    4. Berg D. E.
    Intramolecular transposition by a synthetic IS50 (Tn5) derivative. J. Bacteriol. 172 1990 6348 6354
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Walsh J. H.,
    2. Peterson W. L.
    The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333 1995 984 991
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Wang Y.,
    2. Roos K. P.,
    3. Taylor D. E.
    Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J. Gen. Microbiol. 139 1993 2485 2493
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. York D.,
    2. Welch K.,
    3. Goryshin I. Y.,
    4. Reznikoff W. S.
    Simple and efficient generation in vitro of nested deletions and inversions: Tn5 intramolecular transposition. Nucleic Acids Res. 26 1998 1927 1933
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Insertion of Mini-IS605 and Deletion of Adjacent Sequences in the Nitroreductase (rdxA) Gene Cause Metronidazole Resistance in Helicobacter pyloriNCTC11637
Yvette J. Debets-Ossenkopp, Raymond G. J. Pot, David J. van Westerloo, Avery Goodwin, Christina M. J. E. Vandenbroucke-Grauls, Douglas E. Berg, Paul S. Hoffman, Johannes G. Kusters
Antimicrobial Agents and Chemotherapy Nov 1999, 43 (11) 2657-2662; DOI: 10.1128/AAC.43.11.2657

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Insertion of Mini-IS605 and Deletion of Adjacent Sequences in the Nitroreductase (rdxA) Gene Cause Metronidazole Resistance in Helicobacter pyloriNCTC11637
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Insertion of Mini-IS605 and Deletion of Adjacent Sequences in the Nitroreductase (rdxA) Gene Cause Metronidazole Resistance in Helicobacter pyloriNCTC11637
Yvette J. Debets-Ossenkopp, Raymond G. J. Pot, David J. van Westerloo, Avery Goodwin, Christina M. J. E. Vandenbroucke-Grauls, Douglas E. Berg, Paul S. Hoffman, Johannes G. Kusters
Antimicrobial Agents and Chemotherapy Nov 1999, 43 (11) 2657-2662; DOI: 10.1128/AAC.43.11.2657
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596